Genomic alterations in breast cancer: Level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

  1. Condorelli, R.
  2. Mosele, F.
  3. Verret, B.
  4. Bachelot, T.
  5. Bedard, P.L.
  6. Cortes, J.
  7. Hyman, D.M.
  8. Juric, D.
  9. Krop, I.
  10. Bieche, I.
  11. Saura, C.
  12. Sotiriou, C.
  13. Cardoso, F.
  14. Loibl, S.
  15. Andre, F.
  16. Turner, N.C.
Aldizkaria:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Argitalpen urtea: 2019

Alea: 30

Zenbakia: 3

Orrialdeak: 365-373

Mota: Berrikuspena

DOI: 10.1093/ANNONC/MDZ036 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus